DAVID DOAN: Open Payments
NPI 1437994977 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 51 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $592 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 2 | $154 |
| PFIZER INC. | 6 | $127 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| ABBVIE INC. | 4 | $91 |
| Novo Nordisk Inc | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Amgen Inc. | 3 | $73 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $66 |
| Astellas Pharma US Inc | 3 | $56 |
Products named: XYWAV, JARDIANCE, Sunosi, OTEZLA, PREVNAR 20, UBRELVY, LUMRYZ, ELIQUIS.
Industry payments across NV — which companies pay providers there.
